相关实验视频

Updated: Jan 10, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

在复发性/耐药性外节自然杀手/T细胞淋巴瘤的机制和干预措施

Qisi Lu¹, Tao You², Qian Cheng²

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Department of Hematology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, China.

Drug discovery today

|November 20, 2025

概括

异位性自然杀手/T细胞淋巴瘤 (ENKTL) 是具有攻击性且经常耐治疗的. 本综述探讨了耐药性因素和策略,以改善复发性或耐火性ENKTL.患者的治疗结果.

科学领域:

在瘤学瘤学.
血液学血液学血液学
免疫学免疫学免疫学

背景情况:

外节自然杀手/T细胞淋巴瘤 (ENKTL) 是一种侵略性的非霍奇金淋巴瘤.
它与爱斯坦-巴尔病毒有关,并且经常涉及外节部部位.
基于氨酸酶的疗法现在是标准的,但耐药性仍然是一个重大挑战.

研究的目的:

审查导致ENKTL治疗耐药性的因素.
阐明抵抗的潜在机制.
探索克服ENKTL抗性的潜在策略.

主要方法:

对ENKTL治疗耐药性研究的文献综述.
分析影响耐药性和复发的因素.
检查新兴的治疗策略.

主要成果:

在ENKTL中复发率很高 (40-50%),其中20%的复发/耐药性疾病.
复发性/耐药性ENKTL的预后不佳,平均存活时间小于12个月.
了解耐药机制是开发新治疗方法的关键.

结论:

管理ENKTL,特别是复发/耐药病例,仍然具有挑战性,因为未满足的临床需求.
了解ENKTL生物学方面的进步正在推动开发新型治疗策略.
针对抗药机制提供了改善患者存活率和治疗结果的希望.

关键词:

外节自然杀手/T细胞淋巴瘤新疗法是一种新疗法.复发/耐火性复发/耐火性有针对性的治疗.瘤的药物耐药性瘤的药物耐药性

更多相关视频

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...